BDH Industries Limited (BOM:524828)

Market Cap	2.21B +41.9%
Revenue (ttm)	847.44M +11.8%
Net Income	104.23M +6.9%
EPS	18.11 +7.0%
Shares Out	5.76M
PE Ratio	21.20
Forward PE	n/a
Dividend	4.50 (1.19%)
Ex-Dividend Date	Aug 1, 2025

Volume	318
Average Volume	2,184
Open	386.30
Previous Close	378.90
Day's Range	374.85 - 386.30
52-Week Range	241.00 - 523.75
Beta	0.21
RSI	48.92
Earnings Date	May 22, 2026

About BDH Industries

BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-e...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 112
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524828

Financial Performance

In fiscal year 2025, BDH Industries's revenue was 665.08 million, a decrease of -22.51% compared to the previous year's 858.31 million. Earnings were 92.73 million, a decrease of -6.02%.